γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma

Table 1 Clinicopathological characteristics of the 130 patients with gallbladder adenocarcinoma in this study

Characteristic	mean ± SD or median (IQR) or n (%)
Age, yr	63.23 ± 1.20
Gender
Male	76 (58)
Female	54 (42)
BMI, kg/m2	23.97 ± 0.38
Jaundice
No	111 (85)
Yes	19 (15)
Gallbladder stone
No	68 (52)
Yes	62 (48)
Liver disease
No	118 (91)
Yes	12 (9)
Differentiation stage of cancer cell
Low	21 (16)
Low-medium	26 (20)
Medium	32 (25)
Medium-high	19 (15)
High	18 (14)
TNM stage
I	16 (12)
II	11 (8)
III	83 (65)
IV	20 (15)
CEA, ng/mL	2.59 (1.62-5.50)
CA 19-9, U/mL	47.50 (13.03-220.85)
Maximal tumor diameter, cm	2.70 (1.50-4.55)
GPR	0.17 (0.09-0.44)
Postoperative complications
No	101 (78)
Yes	29 (22)
HOD, D	15 (10-20)
OS, Mo	18 (6-34)

BMI: Body mass index; TNM: Tumor–node–metastasis; CEA: Carcinoembryonic antigen; CA 19-9: Carbohydrate antigen 19-9; GPR: Gamma-glutamyl transferase–to–platelet ratio; HOD: Hospitalization days; OS: Overall survival; SD: Standard deviation; IQR: Interquartile range.